139 related articles for article (PubMed ID: 20868377)
1. Pulsed dye laser-resistant capillary malformation treated using intradermal sclerotherapy with ethanolamine oleate after intense pulsed light treatment.
Hwang SW; Lee HJ; Hong SK; Seo JK; Lee D; Sung H
Dermatol Surg; 2010 Nov; 36(11):1775-8. PubMed ID: 20868377
[No Abstract] [Full Text] [Related]
2. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions.
Costa JR; Torriani MA; Hosni ES; D'Avila OP; de Figueiredo PJ
J Oral Maxillofac Surg; 2011 Jun; 69(6):e88-92. PubMed ID: 21272976
[TBL] [Abstract][Full Text] [Related]
3. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
[TBL] [Abstract][Full Text] [Related]
4. Treatment of capillary malformation using topical timolol combined with 585-nm pulsed dye laser: a prospective, randomized, split-lesion study.
Cheon SJ; Shim WH; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e328-e329. PubMed ID: 28079942
[No Abstract] [Full Text] [Related]
5. Sclerotherapy as an esthetic indication in oral vascular malformations: a case series.
Manzano BR; Premoli AM; Santaella NG; Ikuta CRS; Rubira CMF; Santos PSDS
An Bras Dermatol; 2019; 94(5):521-526. PubMed ID: 31777351
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations.
Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A
Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447
[TBL] [Abstract][Full Text] [Related]
7. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions.
Johann AC; Aguiar MC; do Carmo MA; Gomez RS; Castro WH; Mesquita RA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Nov; 100(5):579-84. PubMed ID: 16243243
[TBL] [Abstract][Full Text] [Related]
8. Arteriovenous malformations: ethanolamine oleate sclerotherapy.
Hyodoh H; Hyodoh K
Acta Chir Iugosl; 2007; 54(3):81-6. PubMed ID: 17988037
[TBL] [Abstract][Full Text] [Related]
9. Complete eradication of duodenal varices after endoscopic injection sclerotherapy with ethanolamine oleate: a case report.
Seo YS; Kwon YD; Park S; Keum B; Park BJ; Kim YS; Jeen YT; Chun HJ; Kim CD; Ryu HS; Um SH
Gastrointest Endosc; 2008 Apr; 67(4):759-62. PubMed ID: 18206152
[No Abstract] [Full Text] [Related]
10. Intradermal injection of normal saline prevents cutaneous complications associated with sclerotherapy for superficial venous malformations.
Kurita M; Ozaki M; Ihara A; Kaji N; Harii K
Plast Reconstr Surg; 2012 Apr; 129(4):772e-774e. PubMed ID: 22456421
[No Abstract] [Full Text] [Related]
11. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck.
Kaji N; Kurita M; Ozaki M; Takushima A; Harii K; Narushima M; Wakita S
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(3):126-36. PubMed ID: 19401940
[TBL] [Abstract][Full Text] [Related]
12. Angiokeratoma of Fordyce treated with 0.5% ethanolamine oleate or 0.25% sodium tetradecyl sulfate.
Seo SH; Chin HW; Sung HW
Dermatol Surg; 2010 Oct; 36(10):1634-7. PubMed ID: 21053421
[No Abstract] [Full Text] [Related]
13. Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results.
Bloom BS; Nelson JS; Geronemus RG
J Am Acad Dermatol; 2015 Aug; 73(2):e71. PubMed ID: 26184004
[No Abstract] [Full Text] [Related]
14. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
Tsutsumi M; Takada A
Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
[No Abstract] [Full Text] [Related]
15. Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Aug; 73(2):e73-4. PubMed ID: 26184005
[No Abstract] [Full Text] [Related]
16. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy.
Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS
Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938
[TBL] [Abstract][Full Text] [Related]
17. Treatment of capillary malformations in capillary malformation-arteriovenous malformation syndrome with pulsed dye laser.
Ang YS; Koh MJA
J Cosmet Dermatol; 2021 Nov; 20(11):3710-3711. PubMed ID: 33655684
[No Abstract] [Full Text] [Related]
18. Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: clinical and experimental studies.
Ozaki M; Kurita M; Kaji N; Fujino T; Narushima M; Takushima A; Harii K
Scand J Plast Reconstr Surg Hand Surg; 2010 Apr; 44(2):75-87. PubMed ID: 20465508
[TBL] [Abstract][Full Text] [Related]
19. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.
Hoque S; Das BK
Pediatr Surg Int; 2011 May; 27(5):527-31. PubMed ID: 21290138
[TBL] [Abstract][Full Text] [Related]
20. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
Neeman A; Leiser A; Kadish U
Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
